Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer?

Eur J Dermatol. 2014 Mar-Apr;24(2):265-7. doi: 10.1684/ejd.2014.2300.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged, 80 and over
  • Combined Modality Therapy
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Melanoma / radiotherapy*
  • Proto-Oncogene Proteins B-raf / genetics
  • Radiation-Sensitizing Agents / therapeutic use
  • Remission Induction
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / radiotherapy*
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Indoles
  • Radiation-Sensitizing Agents
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf